2024-09-18 - Analysis Report
##  MRK Stock Analysis Report

**Company Overview:**  MRK, or Merck & Co., Inc., is a global pharmaceutical company focused on developing and delivering innovative medicines and vaccines. 

**Performance Analysis:**

**1.  Performance vs. S&P 500 (VOO):**

* **Cumulative Return:** MRK: 52.01%, VOO: 89.02%
* **Performance Gap:**  MRK is lagging behind VOO by **-37.01%**,  placing it at **38.01%** on the relative performance scale (where 0% represents the average performance, and 100% represents the best performance).

**2.  Recent Price Movements:**

* **Closing Price:** $117.96
* **5-Day Moving Average:** $115.82
* **20-Day Moving Average:** $116.41
* **60-Day Moving Average:** $120.47

**3.  Technical Indicators:**

* **RSI:** 55.73 (Neutral, suggesting no strong trend)
* **PPO:** 0.21 (Positive, indicating a potential bullish trend)
* **Delta_Previous_Relative_Divergence:** 3.16 (Positive, suggesting a short-term upward trend)
* **Expected_Return:** 11.93% (This represents the potential maximum 5-year expected return on your current invested amount)

**4.  Recent Earnings and Outlook:**

* **Most Recent Earnings (2024-08-05):**
    * **EPS:** $2.15 (Beat Analyst Expectations by $0.15)
    * **Revenue:** $16.11 Billion (Beat Analyst Expectations by $0.5 Billion)

**Overall Analysis:**

MRK has been underperforming compared to the S&P 500 over the long term. However, its recent earnings report has surpassed analyst expectations, potentially suggesting a positive future outlook. Technical indicators also show positive signs, with the PPO indicating a potential bullish trend and the relative divergence suggesting short-term upward momentum. While the RSI is currently neutral, it may show signs of upward movement with continued positive performance.

**Further Research:**

* Analyze MRK's product pipeline and its impact on future earnings growth.
* Evaluate the company's competitive landscape and its ability to maintain its market share.
* Monitor the company's key performance indicators, such as sales growth, operating margins, and research and development spending.

**Disclaimer:** This analysis is for informational purposes only and does not constitute investment advice. Always conduct thorough research and consult with a financial professional before making any investment decisions. 
